

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle exocytosis (GO:0016079) | 5.31012506 |
| 2 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.29496946 |
| 3 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.26693320 |
| 4 | vocalization behavior (GO:0071625) | 5.08700599 |
| 5 | neuron cell-cell adhesion (GO:0007158) | 5.06313968 |
| 6 | glutamate secretion (GO:0014047) | 5.04405463 |
| 7 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.95436105 |
| 8 | synaptic vesicle maturation (GO:0016188) | 4.85337578 |
| 9 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.81421978 |
| 10 | locomotory exploration behavior (GO:0035641) | 4.81077270 |
| 11 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.69957639 |
| 12 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.64619790 |
| 13 | * neuronal action potential propagation (GO:0019227) | 4.63021107 |
| 14 | protein localization to synapse (GO:0035418) | 4.51032708 |
| 15 | presynaptic membrane assembly (GO:0097105) | 4.48188549 |
| 16 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.42761434 |
| 17 | glutamate receptor signaling pathway (GO:0007215) | 4.39872073 |
| 18 | presynaptic membrane organization (GO:0097090) | 4.35036834 |
| 19 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.34576557 |
| 20 | cerebellar granule cell differentiation (GO:0021707) | 4.31438654 |
| 21 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 4.26535940 |
| 22 | serotonin metabolic process (GO:0042428) | 4.23674104 |
| 23 | * neuron-neuron synaptic transmission (GO:0007270) | 4.23197895 |
| 24 | neurotransmitter secretion (GO:0007269) | 4.20513486 |
| 25 | regulation of synaptic vesicle transport (GO:1902803) | 4.16154301 |
| 26 | * synaptic transmission, glutamatergic (GO:0035249) | 4.12621668 |
| 27 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.07525304 |
| 28 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.01410985 |
| 29 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.92810981 |
| 30 | primary amino compound metabolic process (GO:1901160) | 3.92507490 |
| 31 | * gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.87925734 |
| 32 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.87395498 |
| 33 | behavioral response to nicotine (GO:0035095) | 3.85235591 |
| 34 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.82452283 |
| 35 | transmission of nerve impulse (GO:0019226) | 3.78503340 |
| 36 | positive regulation of membrane potential (GO:0045838) | 3.74037824 |
| 37 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.70233125 |
| 38 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.70216041 |
| 39 | exploration behavior (GO:0035640) | 3.69588857 |
| 40 | regulation of postsynaptic membrane potential (GO:0060078) | 3.67336392 |
| 41 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.66289547 |
| 42 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.64304785 |
| 43 | long-term memory (GO:0007616) | 3.62764325 |
| 44 | long-term synaptic potentiation (GO:0060291) | 3.61109100 |
| 45 | C4-dicarboxylate transport (GO:0015740) | 3.55784684 |
| 46 | neurotransmitter transport (GO:0006836) | 3.52813270 |
| 47 | neuron recognition (GO:0008038) | 3.52261476 |
| 48 | proline transport (GO:0015824) | 3.48801918 |
| 49 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.48546139 |
| 50 | central nervous system myelination (GO:0022010) | 3.47070754 |
| 51 | axon ensheathment in central nervous system (GO:0032291) | 3.47070754 |
| 52 | cellular potassium ion homeostasis (GO:0030007) | 3.45842606 |
| 53 | neuronal action potential (GO:0019228) | 3.45360611 |
| 54 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.44853252 |
| 55 | postsynaptic membrane organization (GO:0001941) | 3.41419728 |
| 56 | regulation of synaptic plasticity (GO:0048167) | 3.40976114 |
| 57 | regulation of neurotransmitter secretion (GO:0046928) | 3.38309471 |
| 58 | dendritic spine morphogenesis (GO:0060997) | 3.37809319 |
| 59 | layer formation in cerebral cortex (GO:0021819) | 3.35383564 |
| 60 | regulation of synapse structural plasticity (GO:0051823) | 3.35302413 |
| 61 | * gamma-aminobutyric acid transport (GO:0015812) | 3.34061535 |
| 62 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.32055800 |
| 63 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.31724079 |
| 64 | positive regulation of synapse maturation (GO:0090129) | 3.31562590 |
| 65 | behavioral response to cocaine (GO:0048148) | 3.31111420 |
| 66 | mechanosensory behavior (GO:0007638) | 3.28965871 |
| 67 | auditory behavior (GO:0031223) | 3.28155779 |
| 68 | negative regulation of neurotransmitter transport (GO:0051589) | 3.28139753 |
| 69 | regulation of neurotransmitter levels (GO:0001505) | 3.27418386 |
| 70 | neuromuscular process controlling posture (GO:0050884) | 3.27253538 |
| 71 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.27065265 |
| 72 | L-amino acid import (GO:0043092) | 3.24968715 |
| 73 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.24577140 |
| 74 | membrane hyperpolarization (GO:0060081) | 3.22836369 |
| 75 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 3.22508214 |
| 76 | axonal fasciculation (GO:0007413) | 3.19053549 |
| 77 | * adult walking behavior (GO:0007628) | 3.18471906 |
| 78 | response to histamine (GO:0034776) | 3.16304543 |
| 79 | regulation of neurotransmitter transport (GO:0051588) | 3.14970485 |
| 80 | * membrane depolarization (GO:0051899) | 3.13978719 |
| 81 | synaptic vesicle endocytosis (GO:0048488) | 3.13287122 |
| 82 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.12993593 |
| 83 | regulation of synapse maturation (GO:0090128) | 3.11081188 |
| 84 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.10186960 |
| 85 | synapse assembly (GO:0007416) | 3.09990379 |
| 86 | startle response (GO:0001964) | 3.08295217 |
| 87 | neuromuscular synaptic transmission (GO:0007274) | 3.07817893 |
| 88 | regulation of vesicle fusion (GO:0031338) | 3.07709548 |
| 89 | neuromuscular process controlling balance (GO:0050885) | 3.05498074 |
| 90 | positive regulation of dendritic spine development (GO:0060999) | 3.05050617 |
| 91 | potassium ion import (GO:0010107) | 3.04324081 |
| 92 | membrane depolarization during action potential (GO:0086010) | 3.03622669 |
| 93 | neuronal ion channel clustering (GO:0045161) | 3.02252537 |
| 94 | regulation of dendritic spine development (GO:0060998) | 3.02218301 |
| 95 | behavioral response to ethanol (GO:0048149) | 3.01591786 |
| 96 | retinal cone cell development (GO:0046549) | 3.00830066 |
| 97 | learning (GO:0007612) | 2.98929603 |
| 98 | cell differentiation in hindbrain (GO:0021533) | 2.98243785 |
| 99 | response to auditory stimulus (GO:0010996) | 2.94983290 |
| 100 | * synaptic transmission (GO:0007268) | 2.94925543 |
| 101 | sodium ion export (GO:0071436) | 2.94508379 |
| 102 | positive regulation of synapse assembly (GO:0051965) | 2.94169278 |
| 103 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.93229222 |
| 104 | regulation of synaptic transmission (GO:0050804) | 2.92369111 |
| 105 | behavioral fear response (GO:0001662) | 2.91889653 |
| 106 | behavioral defense response (GO:0002209) | 2.91889653 |
| 107 | long term synaptic depression (GO:0060292) | 2.91747078 |
| 108 | regulation of glutamate secretion (GO:0014048) | 2.90131602 |
| 109 | positive regulation of synaptic transmission (GO:0050806) | 2.89450202 |
| 110 | cellular potassium ion transport (GO:0071804) | 2.89357751 |
| 111 | potassium ion transmembrane transport (GO:0071805) | 2.89357751 |
| 112 | neuromuscular process (GO:0050905) | 2.88668094 |
| 113 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.88103774 |
| 114 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.86010303 |
| 115 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.85788254 |
| 116 | * adult behavior (GO:0030534) | 2.85003827 |
| 117 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.84436337 |
| 118 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.84422286 |
| 119 | calcium ion-dependent exocytosis (GO:0017156) | 2.83896703 |
| 120 | neurotransmitter uptake (GO:0001504) | 2.82867526 |
| 121 | glycine transport (GO:0015816) | 2.82444445 |
| 122 | action potential (GO:0001508) | 2.81565760 |
| 123 | positive regulation of neurotransmitter transport (GO:0051590) | 2.81408399 |
| 124 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.81331765 |
| 125 | glycosphingolipid biosynthetic process (GO:0006688) | 2.79825886 |
| 126 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.79565428 |
| 127 | indole-containing compound metabolic process (GO:0042430) | 2.78320348 |
| 128 | auditory receptor cell stereocilium organization (GO:0060088) | 2.77570657 |
| 129 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.76979004 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.32887309 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.13942672 |
| 3 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.11219725 |
| 4 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.05159723 |
| 5 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.97372359 |
| 6 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.61376266 |
| 7 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.61376266 |
| 8 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.54546036 |
| 9 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.47184680 |
| 10 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.47041742 |
| 11 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.44973811 |
| 12 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.44775484 |
| 13 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.44477946 |
| 14 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.43483281 |
| 15 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.42372453 |
| 16 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.37228334 |
| 17 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.30995973 |
| 18 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.30842151 |
| 19 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.27782624 |
| 20 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.11828918 |
| 21 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.11729842 |
| 22 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.05446056 |
| 23 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.04468456 |
| 24 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.00294055 |
| 25 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.95838807 |
| 26 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.95170194 |
| 27 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.91660539 |
| 28 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.88975654 |
| 29 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.86726517 |
| 30 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.74886194 |
| 31 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.73518742 |
| 32 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.71232056 |
| 33 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.69390356 |
| 34 | P300_19829295_ChIP-Seq_ESCs_Human | 1.62845818 |
| 35 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.60201388 |
| 36 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.60106025 |
| 37 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.59854409 |
| 38 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.53410102 |
| 39 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.53309293 |
| 40 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.52519645 |
| 41 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.50270668 |
| 42 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.49984625 |
| 43 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.48631195 |
| 44 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.45532834 |
| 45 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.45503724 |
| 46 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.43974436 |
| 47 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.42651682 |
| 48 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.41387792 |
| 49 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.40928316 |
| 50 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.40099867 |
| 51 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.39345340 |
| 52 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.38782746 |
| 53 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.34752143 |
| 54 | * EWS_26573619_Chip-Seq_HEK293_Human | 1.32994312 |
| 55 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.32341269 |
| 56 | FUS_26573619_Chip-Seq_HEK293_Human | 1.32214043 |
| 57 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.31140839 |
| 58 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.30969923 |
| 59 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.30610062 |
| 60 | VDR_22108803_ChIP-Seq_LS180_Human | 1.30049347 |
| 61 | AR_25329375_ChIP-Seq_VCAP_Human | 1.27844923 |
| 62 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.27644048 |
| 63 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.27644048 |
| 64 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.26209944 |
| 65 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.23522324 |
| 66 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.23291254 |
| 67 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.21539132 |
| 68 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.21521562 |
| 69 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.21026062 |
| 70 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.20996329 |
| 71 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.20902445 |
| 72 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.20635299 |
| 73 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.19980047 |
| 74 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.19668989 |
| 75 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.19045134 |
| 76 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.17733763 |
| 77 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.16839503 |
| 78 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.16461398 |
| 79 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.15279956 |
| 80 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.15167197 |
| 81 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.14913223 |
| 82 | AR_19668381_ChIP-Seq_PC3_Human | 1.12189565 |
| 83 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.11431074 |
| 84 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.11226812 |
| 85 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.10662046 |
| 86 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.10582224 |
| 87 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.09581811 |
| 88 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.08198894 |
| 89 | TP53_16413492_ChIP-PET_HCT116_Human | 1.07659573 |
| 90 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.06294861 |
| 91 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.05524893 |
| 92 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.05120729 |
| 93 | * KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.04971175 |
| 94 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.04630548 |
| 95 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.04330377 |
| 96 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.04124444 |
| 97 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.03779432 |
| 98 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.03219972 |
| 99 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.03000453 |
| 100 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.02834189 |
| 101 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.02742568 |
| 102 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.02012848 |
| 103 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99930397 |
| 104 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.99642718 |
| 105 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.99227649 |
| 106 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.98129046 |
| 107 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.98024440 |
| 108 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.97323279 |
| 109 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.97099249 |
| 110 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.95139159 |
| 111 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.95139159 |
| 112 | JUN_21703547_ChIP-Seq_K562_Human | 0.94146088 |
| 113 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.91488113 |
| 114 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.90339398 |
| 115 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.90208011 |
| 116 | * PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.89991531 |
| 117 | * E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.89513048 |
| 118 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.88859364 |
| 119 | KDM2B_26808549_Chip-Seq_REH_Human | 0.88367592 |
| 120 | * CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.87773033 |
| 121 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.87761767 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.69509080 |
| 2 | MP0003880_abnormal_central_pattern | 5.29324334 |
| 3 | * MP0003635_abnormal_synaptic_transmissio | 4.00139502 |
| 4 | MP0004270_analgesia | 3.88729472 |
| 5 | * MP0009046_muscle_twitch | 3.53300349 |
| 6 | * MP0009745_abnormal_behavioral_response | 3.46837786 |
| 7 | * MP0002064_seizures | 3.38239997 |
| 8 | MP0002063_abnormal_learning/memory/cond | 3.13687759 |
| 9 | MP0001968_abnormal_touch/_nociception | 3.09765194 |
| 10 | * MP0002272_abnormal_nervous_system | 2.97820358 |
| 11 | MP0001486_abnormal_startle_reflex | 2.83608254 |
| 12 | * MP0002572_abnormal_emotion/affect_behav | 2.80725122 |
| 13 | MP0002734_abnormal_mechanical_nocicepti | 2.75581572 |
| 14 | MP0000569_abnormal_digit_pigmentation | 2.59160479 |
| 15 | MP0002822_catalepsy | 2.59001021 |
| 16 | MP0005423_abnormal_somatic_nervous | 2.47024781 |
| 17 | MP0002736_abnormal_nociception_after | 2.46772207 |
| 18 | MP0002735_abnormal_chemical_nociception | 2.33845677 |
| 19 | MP0001501_abnormal_sleep_pattern | 2.29524725 |
| 20 | MP0001440_abnormal_grooming_behavior | 2.24330803 |
| 21 | * MP0002067_abnormal_sensory_capabilities | 2.19011023 |
| 22 | MP0008569_lethality_at_weaning | 2.13488520 |
| 23 | MP0008877_abnormal_DNA_methylation | 2.01944734 |
| 24 | MP0002733_abnormal_thermal_nociception | 1.99483925 |
| 25 | MP0001970_abnormal_pain_threshold | 1.99004771 |
| 26 | MP0003329_amyloid_beta_deposits | 1.96693180 |
| 27 | MP0000778_abnormal_nervous_system | 1.84511378 |
| 28 | MP0001529_abnormal_vocalization | 1.76496659 |
| 29 | * MP0005386_behavior/neurological_phenoty | 1.76097197 |
| 30 | * MP0004924_abnormal_behavior | 1.76097197 |
| 31 | MP0002184_abnormal_innervation | 1.75127791 |
| 32 | MP0000920_abnormal_myelination | 1.72685274 |
| 33 | MP0004142_abnormal_muscle_tone | 1.68582389 |
| 34 | MP0002557_abnormal_social/conspecific_i | 1.65434917 |
| 35 | MP0009780_abnormal_chondrocyte_physiolo | 1.59609689 |
| 36 | MP0004885_abnormal_endolymph | 1.58701958 |
| 37 | MP0001905_abnormal_dopamine_level | 1.54865301 |
| 38 | MP0001984_abnormal_olfaction | 1.54778050 |
| 39 | MP0005646_abnormal_pituitary_gland | 1.54105123 |
| 40 | MP0003879_abnormal_hair_cell | 1.52721196 |
| 41 | * MP0002066_abnormal_motor_capabilities/c | 1.51540105 |
| 42 | MP0004811_abnormal_neuron_physiology | 1.51364995 |
| 43 | MP0004742_abnormal_vestibular_system | 1.50012032 |
| 44 | * MP0000955_abnormal_spinal_cord | 1.49512303 |
| 45 | * MP0002882_abnormal_neuron_morphology | 1.43505186 |
| 46 | MP0006276_abnormal_autonomic_nervous | 1.41891435 |
| 47 | MP0003633_abnormal_nervous_system | 1.39158271 |
| 48 | MP0004145_abnormal_muscle_electrophysio | 1.32536277 |
| 49 | MP0001188_hyperpigmentation | 1.31390304 |
| 50 | MP0003631_nervous_system_phenotype | 1.27937090 |
| 51 | MP0002102_abnormal_ear_morphology | 1.27207645 |
| 52 | MP0003787_abnormal_imprinting | 1.26125194 |
| 53 | MP0003690_abnormal_glial_cell | 1.26078526 |
| 54 | MP0002638_abnormal_pupillary_reflex | 1.25611466 |
| 55 | MP0002229_neurodegeneration | 1.23039043 |
| 56 | MP0001502_abnormal_circadian_rhythm | 1.15607946 |
| 57 | MP0001485_abnormal_pinna_reflex | 1.13268959 |
| 58 | MP0002909_abnormal_adrenal_gland | 1.11611488 |
| 59 | MP0003632_abnormal_nervous_system | 1.11591069 |
| 60 | MP0005171_absent_coat_pigmentation | 1.10617967 |
| 61 | MP0003646_muscle_fatigue | 1.09304591 |
| 62 | MP0004858_abnormal_nervous_system | 1.07343137 |
| 63 | * MP0002152_abnormal_brain_morphology | 1.06266223 |
| 64 | MP0001963_abnormal_hearing_physiology | 1.03938560 |
| 65 | MP0003634_abnormal_glial_cell | 1.03518805 |
| 66 | * MP0005551_abnormal_eye_electrophysiolog | 1.00348851 |
| 67 | MP0008872_abnormal_physiological_respon | 0.99459724 |
| 68 | MP0003121_genomic_imprinting | 0.98324579 |
| 69 | MP0005253_abnormal_eye_physiology | 0.97343972 |
| 70 | MP0003195_calcinosis | 0.96986100 |
| 71 | MP0005187_abnormal_penis_morphology | 0.94204334 |
| 72 | MP0005645_abnormal_hypothalamus_physiol | 0.93690440 |
| 73 | MP0005409_darkened_coat_color | 0.93622945 |
| 74 | MP0008874_decreased_physiological_sensi | 0.93245069 |
| 75 | MP0004043_abnormal_pH_regulation | 0.90936384 |
| 76 | MP0001177_atelectasis | 0.90412090 |
| 77 | MP0003122_maternal_imprinting | 0.90207982 |
| 78 | MP0002837_dystrophic_cardiac_calcinosis | 0.86488091 |
| 79 | MP0000604_amyloidosis | 0.86234333 |
| 80 | MP0000751_myopathy | 0.85421067 |
| 81 | MP0002069_abnormal_eating/drinking_beha | 0.84963850 |
| 82 | MP0008875_abnormal_xenobiotic_pharmacok | 0.84023094 |
| 83 | * MP0002752_abnormal_somatic_nervous | 0.82938338 |
| 84 | MP0005167_abnormal_blood-brain_barrier | 0.82556770 |
| 85 | MP0004085_abnormal_heartbeat | 0.80492559 |
| 86 | MP0004147_increased_porphyrin_level | 0.80213768 |
| 87 | MP0006072_abnormal_retinal_apoptosis | 0.80113628 |
| 88 | MP0000013_abnormal_adipose_tissue | 0.78893342 |
| 89 | MP0005174_abnormal_tail_pigmentation | 0.76713995 |
| 90 | MP0002160_abnormal_reproductive_system | 0.76657248 |
| 91 | MP0004215_abnormal_myocardial_fiber | 0.73308865 |
| 92 | MP0005535_abnormal_body_temperature | 0.72643631 |
| 93 | MP0010386_abnormal_urinary_bladder | 0.68951231 |
| 94 | MP0004484_altered_response_of | 0.68722872 |
| 95 | MP0006292_abnormal_olfactory_placode | 0.67512920 |
| 96 | MP0000427_abnormal_hair_cycle | 0.66974990 |
| 97 | MP0002928_abnormal_bile_duct | 0.63293055 |
| 98 | MP0004130_abnormal_muscle_cell | 0.63203951 |
| 99 | MP0008057_abnormal_DNA_replication | 0.63118347 |
| 100 | MP0003137_abnormal_impulse_conducting | 0.62899997 |
| 101 | MP0002876_abnormal_thyroid_physiology | 0.62822517 |
| 102 | MP0002090_abnormal_vision | 0.62128710 |
| 103 | MP0005623_abnormal_meninges_morphology | 0.62061712 |
| 104 | MP0001664_abnormal_digestion | 0.61584834 |
| 105 | MP0001943_abnormal_respiration | 0.60048075 |
| 106 | MP0005410_abnormal_fertilization | 0.59949064 |
| 107 | MP0001299_abnormal_eye_distance/ | 0.58550941 |
| 108 | * MP0003698_abnormal_male_reproductive | 0.58316236 |
| 109 | MP0000026_abnormal_inner_ear | 0.58109468 |
| 110 | MP0005195_abnormal_posterior_eye | 0.57286182 |
| 111 | MP0005394_taste/olfaction_phenotype | 0.56727868 |
| 112 | MP0005499_abnormal_olfactory_system | 0.56727868 |
| 113 | MP0002234_abnormal_pharynx_morphology | 0.55262883 |
| 114 | MP0010769_abnormal_survival | 0.54660514 |
| 115 | MP0005389_reproductive_system_phenotype | 0.54136739 |
| 116 | MP0002082_postnatal_lethality | 0.54058766 |
| 117 | MP0010770_preweaning_lethality | 0.54058766 |
| 118 | MP0010768_mortality/aging | 0.51521030 |
| 119 | * MP0000631_abnormal_neuroendocrine_gland | 0.51296104 |
| 120 | MP0001986_abnormal_taste_sensitivity | 0.49369357 |
| 121 | MP0004233_abnormal_muscle_weight | 0.48616931 |
| 122 | MP0003075_altered_response_to | 0.48430317 |
| 123 | * MP0003956_abnormal_body_size | 0.47833405 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 8.25608130 |
| 2 | Myokymia (HP:0002411) | 6.01768260 |
| 3 | Focal seizures (HP:0007359) | 5.73778562 |
| 4 | Atonic seizures (HP:0010819) | 5.70115593 |
| 5 | Epileptic encephalopathy (HP:0200134) | 5.34066518 |
| 6 | Febrile seizures (HP:0002373) | 4.72836661 |
| 7 | Progressive cerebellar ataxia (HP:0002073) | 4.48746719 |
| 8 | Hyperventilation (HP:0002883) | 4.41862415 |
| 9 | Absence seizures (HP:0002121) | 4.38557407 |
| 10 | Visual hallucinations (HP:0002367) | 4.34037700 |
| 11 | Broad-based gait (HP:0002136) | 4.18593887 |
| 12 | Dialeptic seizures (HP:0011146) | 4.14288080 |
| 13 | Action tremor (HP:0002345) | 3.95998236 |
| 14 | Generalized tonic-clonic seizures (HP:0002069) | 3.79912687 |
| 15 | Scanning speech (HP:0002168) | 3.75873258 |
| 16 | Dysmetria (HP:0001310) | 3.56787123 |
| 17 | * Gaze-evoked nystagmus (HP:0000640) | 3.56171015 |
| 18 | Dysdiadochokinesis (HP:0002075) | 3.49530187 |
| 19 | Truncal ataxia (HP:0002078) | 3.29303812 |
| 20 | Poor eye contact (HP:0000817) | 3.28009021 |
| 21 | Supranuclear gaze palsy (HP:0000605) | 3.21026341 |
| 22 | Abnormality of the corticospinal tract (HP:0002492) | 3.19484487 |
| 23 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.18914334 |
| 24 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.18914334 |
| 25 | Neurofibrillary tangles (HP:0002185) | 3.02441546 |
| 26 | Intention tremor (HP:0002080) | 3.01193535 |
| 27 | Ankle clonus (HP:0011448) | 3.00247152 |
| 28 | Spastic gait (HP:0002064) | 2.99153789 |
| 29 | Abnormal social behavior (HP:0012433) | 2.93413992 |
| 30 | Impaired social interactions (HP:0000735) | 2.93413992 |
| 31 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.92045359 |
| 32 | Termporal pattern (HP:0011008) | 2.80606329 |
| 33 | Insidious onset (HP:0003587) | 2.80606329 |
| 34 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.75299451 |
| 35 | Pancreatic cysts (HP:0001737) | 2.74836019 |
| 36 | Abnormal eating behavior (HP:0100738) | 2.73702764 |
| 37 | Anxiety (HP:0000739) | 2.72354771 |
| 38 | Sensory axonal neuropathy (HP:0003390) | 2.71203200 |
| 39 | Absent speech (HP:0001344) | 2.67891086 |
| 40 | Progressive inability to walk (HP:0002505) | 2.67612295 |
| 41 | Cerebral inclusion bodies (HP:0100314) | 2.65265394 |
| 42 | Depression (HP:0000716) | 2.63915149 |
| 43 | Amblyopia (HP:0000646) | 2.63463336 |
| 44 | Hemiparesis (HP:0001269) | 2.62391523 |
| 45 | Impaired smooth pursuit (HP:0007772) | 2.61763287 |
| 46 | Drooling (HP:0002307) | 2.59002121 |
| 47 | Excessive salivation (HP:0003781) | 2.59002121 |
| 48 | Nephronophthisis (HP:0000090) | 2.58408727 |
| 49 | Pheochromocytoma (HP:0002666) | 2.57950225 |
| 50 | Dysmetric saccades (HP:0000641) | 2.56652275 |
| 51 | Pancreatic fibrosis (HP:0100732) | 2.54947235 |
| 52 | Abnormality of binocular vision (HP:0011514) | 2.53653546 |
| 53 | Diplopia (HP:0000651) | 2.53653546 |
| 54 | Postural instability (HP:0002172) | 2.50450179 |
| 55 | Congenital stationary night blindness (HP:0007642) | 2.50419952 |
| 56 | Abnormality of midbrain morphology (HP:0002418) | 2.49674131 |
| 57 | Molar tooth sign on MRI (HP:0002419) | 2.49674131 |
| 58 | Epileptiform EEG discharges (HP:0011182) | 2.48313587 |
| 59 | Type II lissencephaly (HP:0007260) | 2.46367141 |
| 60 | Fetal akinesia sequence (HP:0001989) | 2.46340699 |
| 61 | Generalized myoclonic seizures (HP:0002123) | 2.39814624 |
| 62 | Genetic anticipation (HP:0003743) | 2.38834330 |
| 63 | True hermaphroditism (HP:0010459) | 2.38133033 |
| 64 | Urinary urgency (HP:0000012) | 2.37917714 |
| 65 | Inability to walk (HP:0002540) | 2.37775639 |
| 66 | Status epilepticus (HP:0002133) | 2.33434969 |
| 67 | Hemiplegia (HP:0002301) | 2.30427099 |
| 68 | Blue irides (HP:0000635) | 2.29176932 |
| 69 | Neuroendocrine neoplasm (HP:0100634) | 2.28668441 |
| 70 | EEG with generalized epileptiform discharges (HP:0011198) | 2.28472584 |
| 71 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.27735616 |
| 72 | Abnormality of the renal medulla (HP:0100957) | 2.27715105 |
| 73 | Stereotypic behavior (HP:0000733) | 2.24822892 |
| 74 | Dyskinesia (HP:0100660) | 2.21023946 |
| 75 | Akinesia (HP:0002304) | 2.19960194 |
| 76 | Peripheral hypomyelination (HP:0007182) | 2.19255203 |
| 77 | Abnormality of saccadic eye movements (HP:0000570) | 2.14225478 |
| 78 | Abnormality of the renal cortex (HP:0011035) | 2.13346739 |
| 79 | Clumsiness (HP:0002312) | 2.12825881 |
| 80 | Hypsarrhythmia (HP:0002521) | 2.11888901 |
| 81 | Gait ataxia (HP:0002066) | 2.11756015 |
| 82 | Thickened helices (HP:0000391) | 2.11402416 |
| 83 | Lower limb muscle weakness (HP:0007340) | 2.10673287 |
| 84 | Impaired vibratory sensation (HP:0002495) | 2.10023017 |
| 85 | Protruding tongue (HP:0010808) | 2.09931211 |
| 86 | Bradykinesia (HP:0002067) | 2.06766739 |
| 87 | Polydipsia (HP:0001959) | 2.06469137 |
| 88 | Abnormal drinking behavior (HP:0030082) | 2.06469137 |
| 89 | Limb dystonia (HP:0002451) | 2.05400165 |
| 90 | Decreased central vision (HP:0007663) | 2.05120989 |
| 91 | Lissencephaly (HP:0001339) | 2.05111992 |
| 92 | Gait imbalance (HP:0002141) | 2.04630705 |
| 93 | Attenuation of retinal blood vessels (HP:0007843) | 2.03180229 |
| 94 | Mutism (HP:0002300) | 2.01503464 |
| 95 | Torticollis (HP:0000473) | 2.01348254 |
| 96 | Nephrogenic diabetes insipidus (HP:0009806) | 1.95257940 |
| 97 | Focal dystonia (HP:0004373) | 1.94914543 |
| 98 | Specific learning disability (HP:0001328) | 1.94572871 |
| 99 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.93671649 |
| 100 | Cystic liver disease (HP:0006706) | 1.92828366 |
| 101 | Abnormal hair whorl (HP:0010721) | 1.92747672 |
| 102 | Generalized hypopigmentation of hair (HP:0011358) | 1.92019587 |
| 103 | Polyphagia (HP:0002591) | 1.91915278 |
| 104 | Retinal dysplasia (HP:0007973) | 1.89178248 |
| 105 | Megalencephaly (HP:0001355) | 1.88602775 |
| 106 | Inappropriate behavior (HP:0000719) | 1.88601525 |
| 107 | Incomplete penetrance (HP:0003829) | 1.87214166 |
| 108 | Genital tract atresia (HP:0001827) | 1.86236760 |
| 109 | Postural tremor (HP:0002174) | 1.83910437 |
| 110 | Neuronal loss in central nervous system (HP:0002529) | 1.83676351 |
| 111 | Psychosis (HP:0000709) | 1.82763938 |
| 112 | Clonus (HP:0002169) | 1.82721193 |
| 113 | Cerebral hypomyelination (HP:0006808) | 1.82246838 |
| 114 | Amyotrophic lateral sclerosis (HP:0007354) | 1.81330328 |
| 115 | Agitation (HP:0000713) | 1.81041017 |
| 116 | Abnormality of salivation (HP:0100755) | 1.80456584 |
| 117 | Vaginal atresia (HP:0000148) | 1.79526356 |
| 118 | Widely spaced teeth (HP:0000687) | 1.77584623 |
| 119 | Congenital primary aphakia (HP:0007707) | 1.77349763 |
| 120 | Prolonged QT interval (HP:0001657) | 1.76618231 |
| 121 | Medial flaring of the eyebrow (HP:0010747) | 1.76582763 |
| 122 | Abnormality of the lower motor neuron (HP:0002366) | 1.75610623 |
| 123 | Chronic hepatic failure (HP:0100626) | 1.75585327 |
| 124 | Abolished electroretinogram (ERG) (HP:0000550) | 1.75447480 |
| 125 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.73272422 |
| 126 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.73102645 |
| 127 | Absent/shortened dynein arms (HP:0200106) | 1.73102645 |
| 128 | Fair hair (HP:0002286) | 1.72813638 |
| 129 | Spastic tetraplegia (HP:0002510) | 1.71022895 |
| 130 | Papilledema (HP:0001085) | 1.70271409 |
| 131 | Craniofacial dystonia (HP:0012179) | 1.69610384 |
| 132 | Abnormality of the labia minora (HP:0012880) | 1.68162976 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 4.53523712 |
| 2 | EPHA4 | 4.06709126 |
| 3 | NTRK3 | 3.81959887 |
| 4 | CASK | 3.50938699 |
| 5 | MAP3K9 | 2.90193454 |
| 6 | CDK19 | 2.83208097 |
| 7 | MAP3K4 | 2.80721938 |
| 8 | OXSR1 | 2.59327921 |
| 9 | MAP2K7 | 2.53182588 |
| 10 | DAPK2 | 2.39305007 |
| 11 | TNIK | 2.12557306 |
| 12 | MINK1 | 2.10466796 |
| 13 | MAP3K12 | 2.07875456 |
| 14 | PAK6 | 2.07586348 |
| 15 | PRPF4B | 2.05363238 |
| 16 | STK39 | 2.03194686 |
| 17 | MARK1 | 1.98959606 |
| 18 | RIPK4 | 1.86831770 |
| 19 | CAMKK2 | 1.83286786 |
| 20 | PNCK | 1.79733396 |
| 21 | MAP2K4 | 1.78317556 |
| 22 | NTRK2 | 1.64242998 |
| 23 | NTRK1 | 1.62151947 |
| 24 | PLK2 | 1.58369411 |
| 25 | MAP4K2 | 1.54234481 |
| 26 | ADRBK2 | 1.52970964 |
| 27 | KSR2 | 1.47854907 |
| 28 | CDK5 | 1.47482812 |
| 29 | CAMKK1 | 1.42957153 |
| 30 | DAPK1 | 1.35781626 |
| 31 | BMPR1B | 1.32536855 |
| 32 | GRK5 | 1.26657623 |
| 33 | SGK494 | 1.22918938 |
| 34 | SGK223 | 1.22918938 |
| 35 | ARAF | 1.20577429 |
| 36 | GRK1 | 1.19810878 |
| 37 | KSR1 | 1.18926057 |
| 38 | WNK1 | 1.18248843 |
| 39 | CAMK2B | 1.17384070 |
| 40 | MAPK13 | 1.17094416 |
| 41 | UHMK1 | 1.16969621 |
| 42 | BCR | 1.14934801 |
| 43 | PRKCG | 1.14562962 |
| 44 | CAMK2A | 1.13899204 |
| 45 | MAP3K13 | 1.09268319 |
| 46 | AKT3 | 1.04438941 |
| 47 | INSRR | 0.99798633 |
| 48 | CDK18 | 0.99206843 |
| 49 | CCNB1 | 0.98541653 |
| 50 | FES | 0.97479178 |
| 51 | SIK2 | 0.96664829 |
| 52 | BMPR2 | 0.96614523 |
| 53 | CDK15 | 0.96592769 |
| 54 | CDK14 | 0.96267543 |
| 55 | TYRO3 | 0.92229941 |
| 56 | MKNK2 | 0.89489188 |
| 57 | PRKD3 | 0.88909687 |
| 58 | NEK6 | 0.88895440 |
| 59 | SGK2 | 0.87552689 |
| 60 | STK11 | 0.86603107 |
| 61 | CSNK1A1L | 0.86212722 |
| 62 | CDK11A | 0.83614372 |
| 63 | ACVR1B | 0.83575692 |
| 64 | CAMK1 | 0.80564255 |
| 65 | CAMK2D | 0.80485142 |
| 66 | WNK4 | 0.80376015 |
| 67 | MAP3K2 | 0.79745027 |
| 68 | PTK2B | 0.79060419 |
| 69 | FGFR2 | 0.78524929 |
| 70 | CSNK1G2 | 0.77954304 |
| 71 | MAPKAPK5 | 0.74700102 |
| 72 | PKN1 | 0.74541646 |
| 73 | SGK1 | 0.72932593 |
| 74 | ROCK2 | 0.72145738 |
| 75 | TAOK3 | 0.71763852 |
| 76 | CAMK2G | 0.71352945 |
| 77 | MUSK | 0.71333882 |
| 78 | STK38 | 0.71265686 |
| 79 | PDPK1 | 0.70158526 |
| 80 | PRKCH | 0.69399001 |
| 81 | DYRK2 | 0.68573113 |
| 82 | PRKCE | 0.68518811 |
| 83 | PAK3 | 0.67287192 |
| 84 | ADRBK1 | 0.66446920 |
| 85 | CSNK1G1 | 0.65988223 |
| 86 | FGR | 0.64481644 |
| 87 | PDK1 | 0.63954508 |
| 88 | SGK3 | 0.62673925 |
| 89 | DYRK1A | 0.61272970 |
| 90 | NUAK1 | 0.60909481 |
| 91 | MARK2 | 0.59995997 |
| 92 | PINK1 | 0.59255582 |
| 93 | ZAK | 0.58392377 |
| 94 | PHKG2 | 0.56307776 |
| 95 | PHKG1 | 0.56307776 |
| 96 | SIK3 | 0.53635291 |
| 97 | PIK3CA | 0.52812895 |
| 98 | RET | 0.52221828 |
| 99 | RAF1 | 0.51861310 |
| 100 | TRIM28 | 0.51341046 |
| 101 | TNK2 | 0.50573095 |
| 102 | CAMK1D | 0.50283263 |
| 103 | FYN | 0.47808084 |
| 104 | PRKCA | 0.42270755 |
| 105 | RPS6KA3 | 0.41833699 |
| 106 | BRAF | 0.41832219 |
| 107 | DAPK3 | 0.41715222 |
| 108 | CAMK1G | 0.40527875 |
| 109 | CAMK4 | 0.40326954 |
| 110 | ERBB2 | 0.39928019 |
| 111 | PRKCB | 0.39192882 |
| 112 | MAP3K1 | 0.39099336 |
| 113 | WNK3 | 0.38607598 |
| 114 | PRKAA1 | 0.38332117 |
| 115 | PRKG1 | 0.37554600 |
| 116 | CSNK1G3 | 0.37016710 |
| 117 | PRKACA | 0.36910350 |
| 118 | MAPK7 | 0.36905625 |
| 119 | PRKCQ | 0.36260717 |
| 120 | MAPK10 | 0.35444023 |
| 121 | PRKCZ | 0.34640907 |
| 122 | MAPK12 | 0.33335607 |
| 123 | TXK | 0.32743475 |
| 124 | CSNK1A1 | 0.32387265 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.01145210 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.40003164 |
| 3 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.92008339 |
| 4 | GABAergic synapse_Homo sapiens_hsa04727 | 2.83674041 |
| 5 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.78479320 |
| 6 | Long-term potentiation_Homo sapiens_hsa04720 | 2.66670584 |
| 7 | Circadian entrainment_Homo sapiens_hsa04713 | 2.65515106 |
| 8 | Morphine addiction_Homo sapiens_hsa05032 | 2.65071366 |
| 9 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.42950906 |
| 10 | Olfactory transduction_Homo sapiens_hsa04740 | 2.42076458 |
| 11 | Salivary secretion_Homo sapiens_hsa04970 | 2.20329561 |
| 12 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.13292931 |
| 13 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.09509811 |
| 14 | Long-term depression_Homo sapiens_hsa04730 | 1.98099598 |
| 15 | Taste transduction_Homo sapiens_hsa04742 | 1.97253363 |
| 16 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.86778713 |
| 17 | Insulin secretion_Homo sapiens_hsa04911 | 1.81498993 |
| 18 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.80578099 |
| 19 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.80260395 |
| 20 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.76296832 |
| 21 | Renin secretion_Homo sapiens_hsa04924 | 1.69396918 |
| 22 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.62444548 |
| 23 | Cocaine addiction_Homo sapiens_hsa05030 | 1.57358512 |
| 24 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.57121004 |
| 25 | * Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.50848448 |
| 26 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.44894551 |
| 27 | * Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.43589132 |
| 28 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.27436535 |
| 29 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.27144850 |
| 30 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.24934375 |
| 31 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.23590981 |
| 32 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.23322012 |
| 33 | Axon guidance_Homo sapiens_hsa04360 | 1.22907362 |
| 34 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.22546664 |
| 35 | Gap junction_Homo sapiens_hsa04540 | 1.22127917 |
| 36 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.17356033 |
| 37 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.16733209 |
| 38 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.12942254 |
| 39 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.11065751 |
| 40 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.07345046 |
| 41 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.05226621 |
| 42 | * Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.00635021 |
| 43 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.98533937 |
| 44 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.97772802 |
| 45 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.97037001 |
| 46 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.95042947 |
| 47 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.94753305 |
| 48 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.93982762 |
| 49 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.92489606 |
| 50 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.90353691 |
| 51 | Alzheimers disease_Homo sapiens_hsa05010 | 0.89619313 |
| 52 | Phototransduction_Homo sapiens_hsa04744 | 0.88956692 |
| 53 | ABC transporters_Homo sapiens_hsa02010 | 0.87906638 |
| 54 | Melanogenesis_Homo sapiens_hsa04916 | 0.85571261 |
| 55 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.79089378 |
| 56 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.75411999 |
| 57 | Glioma_Homo sapiens_hsa05214 | 0.74929456 |
| 58 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.72175234 |
| 59 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.70857991 |
| 60 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.70091870 |
| 61 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.69171252 |
| 62 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.68157812 |
| 63 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.67878190 |
| 64 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.67421015 |
| 65 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.67400387 |
| 66 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.66570431 |
| 67 | * MAPK signaling pathway_Homo sapiens_hsa04010 | 0.65884106 |
| 68 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.64083615 |
| 69 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.63737164 |
| 70 | Histidine metabolism_Homo sapiens_hsa00340 | 0.62911926 |
| 71 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.61653487 |
| 72 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.61243723 |
| 73 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.60118108 |
| 74 | Parkinsons disease_Homo sapiens_hsa05012 | 0.60105547 |
| 75 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.58398466 |
| 76 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.55372321 |
| 77 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.54727363 |
| 78 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.54724461 |
| 79 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.52969933 |
| 80 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.52706024 |
| 81 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.50749455 |
| 82 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.50658378 |
| 83 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.49940200 |
| 84 | * Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.49817071 |
| 85 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.48881305 |
| 86 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.48760228 |
| 87 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.48017197 |
| 88 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.47057259 |
| 89 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.46871530 |
| 90 | Endocytosis_Homo sapiens_hsa04144 | 0.45315533 |
| 91 | Alcoholism_Homo sapiens_hsa05034 | 0.45057210 |
| 92 | Circadian rhythm_Homo sapiens_hsa04710 | 0.44295744 |
| 93 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.43166310 |
| 94 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.41383800 |
| 95 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.40867512 |
| 96 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.37673781 |
| 97 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.37056715 |
| 98 | Mineral absorption_Homo sapiens_hsa04978 | 0.35882491 |
| 99 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.35496051 |
| 100 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.35315779 |
| 101 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.35001338 |
| 102 | Bile secretion_Homo sapiens_hsa04976 | 0.32764731 |
| 103 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.32687506 |
| 104 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.32081027 |
| 105 | Huntingtons disease_Homo sapiens_hsa05016 | 0.31754746 |
| 106 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.31425893 |
| 107 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.30984394 |
| 108 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.30564956 |
| 109 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.29466801 |
| 110 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.26826256 |
| 111 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.26136510 |
| 112 | Tight junction_Homo sapiens_hsa04530 | 0.25284623 |
| 113 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.24617786 |
| 114 | Phagosome_Homo sapiens_hsa04145 | 0.24343648 |
| 115 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.24304741 |
| 116 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.24121502 |
| 117 | Prion diseases_Homo sapiens_hsa05020 | 0.23684728 |
| 118 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.23487205 |
| 119 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.23467389 |
| 120 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.20183430 |
| 121 | Peroxisome_Homo sapiens_hsa04146 | 0.17267690 |

